Search

everythinglearnresearchcommunity

for

Search:↓

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Phytoandrogens from plants may help treat low testosterone naturally.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

New treatments for hair loss are being developed using molecular biology.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Androgens increase cervical cancer risk and affect its development.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.